LensAR declared that the LensAR Laser System has received the FDA 510(k) clearance for performing lens fragmentation and anterior capsulotomy during cataract operations.
The LensAR Laser System assists surgeons performing refractive cataract surgeries to be equipped with the latest medical equipment. Surgeons can improve their proficiency in cataract surgery as the laser system, with its 3D-CSI imaging and biometry system, is effective in imaging and evaluating the structure at all levels of cataract.
The 3D-CSI delivers high-resolution, high contrast distortion-free images from the cornea’s frontal surface to the posterior capsule. The high-precision LensAR Laser System can be used to make an accurate capsulotomy incision for extracting high grade cataracts.
The LensAR Laser System has been used in a number of cataract surgeries for many patients outside the U.S. The medical equipment is used only for investigational purposes.
The Managing Director of LensAR, Louis “Skip” Nichamin, stated that the lens fragmentation and removal process was more effective and accurate in removing higher grades of cataract than the typical phacoemulsification process. He added that the FDA clearance of the LensAR Laser System may transform the future of lens replacement surgery.